MESOTHELINIC CAR RECEPTORS AND USE THEREOF Russian patent published in 2024 - IPC C07K14/705 C07K16/28 C07K16/30 A61K39/00 A61P35/00

Abstract RU 2822193 C2

FIELD: biotechnology.

SUBSTANCE: there are presented: a polypeptide composition specifically interacting with human mesothelin, an immunoreactive cell for enhancing the immune response to cancer and a method for preparing the same, a pharmaceutical composition for enhancing the immune response to cancer, a nucleic acid composition for producing an immunoreactive cell and an expression vector. Also disclosed is a kit for enhancing the immune response to cancer, a method of treating neoplasia in a subject and treating a subject having a recurrent neoplasia, method of increasing or prolonging the survival rate of a subject having neoplasia, a method of reducing a tumour load in a subject, a method of increasing production of an immunoactivating cytokine in response to a cancer cell or a pathogen in a subject, a method of treating an inflammatory disease in a subject and a method for preventing transplant rejection in a subject.

EFFECT: invention is used to enhance the immune response to cancer, as well as to increase the production of an immunoactivating cytokine in response to a cancer cell or pathogen in a subject.

90 cl, 13 tbl, 94 dwg, 6 ex

Similar patents RU2822193C2

Title	Year	Author	Number
TYPES OF COMBINATION THERAPY USING CHIMERIC ANTIGEN RECEPTORS AND PD-1 INHIBITORS	2017	Anak, Ozlem Bajlik, Sejnela Brogdon, Dzhennifer Kemeron, Dzhon, Skott Chou, Uillyam Khauard, Denni, Roland, Ml. Isaaks, Randi Dzhun, Karl, Kh. Lejsi, Sajmon Mod, Shennon Milenkhorst, Yan, Dzh. Shaster, Stiven Kintas-Kardama, Alfonso Grapp, Stefan Bitter, Khans	RU2809160C2
CHIMERIC ANTIGENE RECEPTORS TARGETTING FLT3	2018	Sasu, Barbra Johnson Dettling, Danielle Elizabeth Sommer, Cesar Adolfo Yeung, Yik Andy Hamze, Moustafa Marc	RU2820859C2
MUC16-SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND THEIR USE	2019	Sabzevari, Khelen Shakh, Rutul R.	RU2795198C2
CHIMERIC ANTIGEN RECEPTORS AND BINDING AGENTS TARGETING DLL3	2020	Chzhan, I Van Blarkom, Tomas Dzhon Panovski, Siler Tacheva-Grigorova, Silviya K. Sasu, Barbra Dzhonson	RU2822366C2
CHIMERIC ANTIGENIC (CAR) RECEPTOR AGAINST CD123 FOR USE IN TREATING MALIGNANT TUMORS	2015	Brogdon, Jennifer Gill, Saar Glass, David Kenderian, Saad Loew, Andreas Mannick, Joan Milone, Michael Murphy, Leon Porter, David, L. Ruella, Marco Wang, Yongqiang Wu, Qilong Zhang, Jiquan	RU2724999C2
CHIMERIC ANTIGEN RECEPTORS TARGETING CD70	2019	Srivatsa Srinivasan, Surabhi Nagarajan, Niranjana Aditi Panowski, Siler Park, Yoon Sai, Tao Sasu, Barbra Johnson Van Blarcom, Thomas John Dusseaux, Mathilde Brunnhilde Galetto, Roman Ariel	RU2801824C2
TREATMENT OF MALIGNANT NEOPLASM USING HUMANIZED CHIMERIC ANTIGEN RECEPTOR AGAINST BCMA	2015	Brogdon, Jennifer Choi, Eugene Ebersbach, Hilmar Glass, David Huet, Heather June, Carl, H. Mannick, Joan Milone, Michael, C. Murphy, Leon Plesa, Gabriela Richardson, Celeste Ruella, Marco Singh, Reshma Wang, Yongqiang Wu, Qilong	RU2751660C2
COMPOSITIONS AND METHODS OF SELECTIVE PROTEIN DEGRADATION	2018	Golosov, Andrei Goold, Carleton, Proctor Guimaraes, Carle, Patricia Pinto Hild, Marc Horst Peter Motz, Gregory Ross, Nathan Thomas Solomon, Jonathan, M. Beckwith, Rohan, Eric John Carbonneau, Seth Bradner, James, E.	RU2811700C2
CHIMERIC ANTIGEN RECEPTOR	2018	Tamada Koji Sakoda Yukimi Ishizaki Hidenobu	RU2770002C2
CHIMERIC ANTIGEN RECEPTOR	2016	Pyule Marten Kordoba Shon	RU2752880C2

RU 2 822 193 C2

Authors

Adusumilli, Prasad, S.

Sadelain, Michel

Dates

2024-07-03—Published

2020-05-18—Filed